NUTX

Nutex Health

114.61 USD
-3.00
2.55%
At close Jul 11, 4:00 PM EDT
After hours
113.21
-1.40
1.22%
1 day
-2.55%
5 days
-3.59%
1 month
-5.10%
3 months
-13.19%
6 months
272.59%
Year to date
230.10%
1 year
2,302.73%
5 years
-98.09%
10 years
-98.09%
 

About: Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Employees: 830

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

66% more capital invested

Capital invested by funds: $28.7M [Q4 2024] → $47.7M (+$18.9M) [Q1 2025]

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

12% more funds holding

Funds holding: 41 [Q4 2024] → 46 (+5) [Q1 2025]

1.97% more ownership

Funds ownership: 16.67% [Q4 2024] → 18.64% (+1.97%) [Q1 2025]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$225
96%
upside
Avg. target
$263
129%
upside
High target
$300
162%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Maxim Group
Anthony Vendetti
96%upside
$225
Buy
Maintained
20 May 2025
Benchmark
Bill Sutherland
162%upside
$300
Buy
Maintained
15 May 2025

Financial journalist opinion

Based on 5 articles about NUTX published over the past 30 days

Neutral
PRNewsWire
3 days ago
NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS
HOUSTON , July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced various community-driven accolades the Company and its hospitals received in the second quarter of 2025. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.
NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS
Positive
Seeking Alpha
1 week ago
Nutex Health: Justified Dilution Given Explosive Growth In Free Cash Flow
Nutex Health delivered a blowout Q1 2025, with $51M in free cash flow and 214% y/y revenue growth, driven by arbitration wins. A frank discussion of its equity dilution. The company's growth is impressive but erratic, with limited visibility and heavy reliance on non-recurring arbitration revenue.
Nutex Health: Justified Dilution Given Explosive Growth In Free Cash Flow
Neutral
PRNewsWire
2 weeks ago
NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT
HOUSTON , June 27, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced that it has filed a supplement to the proxy statement it filed on June 2, 2025. The Company encourages shareholders to review the supplement filed today.
NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT
Neutral
PRNewsWire
2 weeks ago
NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
HOUSTON , June 24, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced it has been added as a member of the broad-market Russell 3000® Index and the Russell Microcap® Index, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell US indexes captures the 4,000 largest U.S. stocks as of April 30, ranking them by total market capitalization.
NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX
Positive
Seeking Alpha
3 weeks ago
Nutex Health Leverages Arbitration To Unlock Hidden Value
Nutex Health is a speculative buy, exploiting a unique arbitrage model under the No Surprises Act for strong revenue and profit growth. The micro-hospital strategy, physician ownership, and focus on efficiency drive staff stability and operational expansion, supporting sustainable volume growth. Financials are robust: Q1 saw a 213% sales jump, a 56% gross margin, strong cash flow, and a healthy balance sheet with modest debt.
Nutex Health Leverages Arbitration To Unlock Hidden Value
Neutral
PRNewsWire
1 month ago
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
HOUSTON , June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2025 annual meeting to be held on July 14, 2025 at 10:00 am Central Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2025 . We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote.
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
Positive
Seeking Alpha
1 month ago
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong Momentum
NUTX is transforming from a turnaround story to a high-growth, high-risk play, driven by explosive revenue and profitability from its micro-hospital model. The company's financials show triple-digit revenue growth, margin expansion, and strong operating leverage, with positive analyst sentiment and technical momentum. Key risks include heavy reliance on arbitration revenue, significant lease liabilities, and regulatory uncertainty, making this a volatile but compelling opportunity.
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong Momentum
Neutral
PRNewsWire
1 month ago
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
HOUSTON , May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company.
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
Neutral
Seeking Alpha
1 month ago
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
Nutex Health Inc. (NASDAQ:NUTX ) Q1 2025 Earnings Conference Call May 14, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - IR Manager Tom Vo - Chairman and CEO Jon Bates - CFO Warren Hosseinion - President Josh DeTillio - COO Conference Call Participants Bill Sutherland - The Benchmark Company Thomas McGovern - Maxim Group Gene Mannheimer - Freedom Capital Markets Joshua Cohen - Westbury Capital Operator Greetings. Welcome to Nutex Health's First Quarter 2025 Financial Results Conference Call.
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
Neutral
PRNewsWire
1 month ago
NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8% NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET LOSS OF $0.4 MILLION IN Q1 2024 DILUTED EPS OF $2.56 PER SHARE VERSUS $(0.08) PER SHARE IN Q1 2024 EBITDA OF $43.1 MILLION VERSUS $7.1 MILLION IN EBITDA IN Q1 2024, AN INCREASE OF 507.0% ADJUSTED EBITDA OF $72.8 MILLION VERSUS $(0.4) MILLION IN Q1 2024 NET CASH FROM OPERATING ACTIVITIES OF $51.0 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS HAVE RESULTED IN MORE FAIR AND REASONABLE PAYMENTS HOUSTON , May 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced first quarter 2025 financial results for the three months ended March 31, 2025.
NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Charts implemented using Lightweight Charts™